Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulla Hansen

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
BMC Cancer|June 17, 2020
Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescenceJennifer L S Willoughby, Kelly George, Mark P Roberto, et al.
Circulation|September 22, 2012
Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injurySophie J Bernelot Moens, Gavin R Schnitzler, Moriah Nickerson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2010
Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinomaByoung Kwon Yoo, Luni Emdad, Rachel Gredler, et al.
The American Journal of Pathology|June 16, 2022
Pharmacologic Manipulation of Late SV40 Factor Suppresses Wnt Signaling and Inhibits Growth of Allogeneic and Syngeneic Colon Cancer XenograftsSaran Lotfollahzadeh, Dominic Lo, Emily A York, et al.
Plos One|June 15, 2022
Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteinsSarah A Yunes, Jennifer L S Willoughby, Julian H Kwan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2012
Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinomaTrevor J Grant, Joshua A Bishop, Lisa M Christadore, et al.
Oncotarget|August 28, 2015
Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC modelDevaraja Rajasekaran, Ayesha Siddiq, Jennifer L S Willoughby, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
BMC Cancer|June 17, 2020
Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescenceJennifer L S Willoughby, Kelly George, Mark P Roberto, et al.
Circulation|September 22, 2012
Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injurySophie J Bernelot Moens, Gavin R Schnitzler, Moriah Nickerson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2010
Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinomaByoung Kwon Yoo, Luni Emdad, Rachel Gredler, et al.
The American Journal of Pathology|June 16, 2022
Pharmacologic Manipulation of Late SV40 Factor Suppresses Wnt Signaling and Inhibits Growth of Allogeneic and Syngeneic Colon Cancer XenograftsSaran Lotfollahzadeh, Dominic Lo, Emily A York, et al.
Plos One|June 15, 2022
Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteinsSarah A Yunes, Jennifer L S Willoughby, Julian H Kwan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2012
Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinomaTrevor J Grant, Joshua A Bishop, Lisa M Christadore, et al.
Oncotarget|August 28, 2015
Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC modelDevaraja Rajasekaran, Ayesha Siddiq, Jennifer L S Willoughby, et al.
Pageof 5